Robotic-Assisted Laparoscopic Partial Nephrectomy Periprocedural Care
- Author: E Jason Abel, MD; Chief Editor: Edward David Kim, MD, FACS more...
Patient Education & Consent
Once a decision has been made to proceed with surgery, the patient must be carefully counseled on all options available, including open partial nephrectomy, open or laparoscopic radical nephrectomy, percutaneous procedures such as cryoablation and thermal ablation, and observation. Risks and benefits attendant to each procedure should be explained and placed honestly in the context of the surgeon’s individual experience and outcomes.
The authors’ preference is to request that each patient drink one bottle of magnesium citrate the night before surgery to decompress the bowel and facilitate colon mobilization. The authors do not routinely employ a full bowel preparation.
As appropriate, patients are requested to stop smoking well in advance of surgery, to stay active, and to maintain a good diet. Platelet inhibitors are stopped well in advance of surgery. A set of specific instructions detailing each expected step of the hospitalization, discharge, and postoperative period is given to each patient; this should be specific to the surgeon and the patient, including details such as likelihood of drain placement, type of incision closure, recommendations for postoperative activity, and an estimate of the patient’s postoperative functional ability to allow appropriate support planning.
Elements of Informed Consent
Specific risks that require careful and complete discussion during informed consent for robotic-assisted partial nephrectomy include bleeding, infection, urinary leak, acute kidney injury secondary to ischemia, the likelihood and implication of positive oncologic margins, bowel injury, and significant vascular injury. These factors should be personalized to each patient and each tumor and should include a discussion of the possibility of conversion to open or laparoscopic radical nephrectomy and the renal functional implications thereof. General risks to be discussed include transfusion, deep venous thrombosis/pulmonary embolism, neuropathy, rhabdomyolysis, and pneumonia.
Robot-assisted partial nephrectomy requires an emphasis on the team approach to surgery. The primary assistant and the operating room nursing staff are vital to the success of the procedure.
The assistant is responsible for critical tasks such as hilar clamp application, introduction of the sutures and clips, and provision of suction and countertraction during the tumor excision.
The robotic console for da Vinci surgical robot
The user interface for the surgeon consists of the display system, master arms, control/touchpad, and footswitch panel.
Display system: The current system provides a 3-dimensional stereoscopic high-definition display with up to 10X magnification for the surgeon in the console, and additional 2-dimensional displays are available for the rest of the operating room team. The Si model also has dual console capabilities to facilitate training, with a second console with 3-dimensional vision and ability to take control of the instruments.
Master arms: The master controls take input from the surgeon’s finger and thumb and translate the operator’s movements in real time to the robotic arms and EndoWrist instruments. Some basic force feedback is also provided to the surgeon. Motion-scaling settings allow the scaling of hand-to-instrument movement ratios.
Control/touchpad: At the surgeon console, an integrated surgeon interface allows control of the video, audio, and system settings for the console surgeon. These include toggling between 2-dimensional and 3-dimensional display, adjusting motion scaling, and choosing camera perspectives. Unique user settings can be stored in each surgeon’s user profile, and the surgeon can benefit from the available ergonomic settings to minimize fatigue. The newer Si model features a programmable touchpad.
Footswitch panel: Moving the camera, swapping between different types of energy, and deploying diathermy is controlled with a clutch mechanism and foot switches.
The da Vinci system consists of 2 or 3 arms for mounting surgical instruments, and a separate camera arm is dedicated for the camera.
The robotic arms are mounted on a mobile platform that is draped and secured in place alongside the patient once the patient is appropriately positioned.
The arms are mounted to 8-mm trocars placed through the patient’s abdominal wall.
The arms are controlled by the surgeon within the console, and instrument exchange, suctioning, and suture delivery is performed by the assisting surgeon at the bedside, alongside the robotic arms.
Port placement and installation of the robot is obviously an important aspect of this procedure. It is important to consider the timing of docking the robot, as table rotation will not be possible with the robot docked.
Patient preparation is limited to administration of one bottle of magnesium citrate orally the night before surgery to decompress the bowel and administration of a second-generation cephalosporin antimicrobial prior to incision.
General anesthesia is used.
After general anesthesia is administered, an NG tube is placed, and a Foley catheter is inserted, the patient is placed in a modified lateral position with a gel roll behind the buttock and another behind the shoulder. Alternatively, a bean bag and cloth tape can be used to support the patient.
Table flexion allows an increased working space for the instruments and avoids clashing of the robotic arms during the procedure, and most surgeons continue to prefer a flank position with the table moderately flexed.
An axillary roll may be placed to avoid brachial plexus injury, and all pressure points are padded and protected accordingly. The upper arm may be secured above the down arm or positioned in the "upper arm adducted" position along the patient's hip, as demonstrated below.
The table is flexed to about 20°. Other authors suggest that inclining the operating table by 30°-45° provides more room on the side of the robot to accommodate the vision cart and the laparoscopic boom and monitors and to allow movement of personnel. The patient is then secured to the table with heavy tape across the hips and shoulders.
The older "standard" Da Vinci robot design permits only minimal side-to-side movement, and precise port placement is essential. For this reason, Kaul et al have modified the traditional port placement template for robotic partial nephrectomy by placing the camera port laterally and the robotic instruments closer to the umbilicus when using this system. This modification obviates the need for retraction of the colon, and an enhanced range of motion of the robotic arms is accomplished. Subsequently, dissection of the upper and lower poles of the kidney and adjacent organs such as liver and duodenum on the right and spleen on the left is facilitated.
Surgeons using the standard model Da Vinci unit may choose to perform portions of the dissection and renal mobilization laparoscopically, focusing on use of the robot for the resection and renorrhaphy. This approach takes full advantage of the vision and dexterity provided by the robotic platform for the critical portions of partial nephrectomy while avoiding the limitations of the first-generation system.
Monitoring & Follow-up
Follow-up after surgery is similar to that after open partial nephrectomy. Patients undergo a history and physical examination, as well as laboratory tests, at intervals after surgery as outlined in the NCCN guideline according to risk of recurrence as defined by the stage and grade of tumor. Local recurrence after surgery for pT1 renal cell carcinoma is very rare (< 5% in 5 years), and recurrence is most common in the lung.
Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int. 2010 Nov. 106(9):1277-83. [Medline].
Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969 Mar. 101(3):297-301. [Medline].
Russo P, Huang W. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am. 2008 Nov. 35(4):635-43; vii. [Medline].
Herr HW. A history of partial nephrectomy for renal tumors. J Urol. 2005 Mar. 173(3):705-8. [Medline].
Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011 Oct. 60(4):662-72. [Medline].
Maclennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, et al. Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer. Eur Urol. 2012 Feb 25. [Medline].
Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011 Apr. 59(4):543-52. [Medline].
Novick AC, Campbell SC, Belldegrun, A, Blute ML, Chow, et al. Guideline for Management of the Clinical Stage 1 Renal Mass (2009). [Full Text].
Lane BR, Gill IS. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol. 2010 Feb. 183(2):473-9. [Medline].
Colombo JR Jr, Haber GP, Jelovsek JE, Nguyen M, Fergany A, Desai MM. Complications of laparoscopic surgery for urological cancer: a single institution analysis. J Urol. 2007 Sep. 178(3 Pt 1):786-91. [Medline].
Benway BM, Bhayani SB, Rogers CG, Dulabon LM, Patel MN, Lipkin M, et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol. 2009 Sep. 182(3):866-72. [Medline].
Rassweiler JJ, Henkel TO, Potempa DM, Coptcoat M, Alken P. The technique of transperitoneal laparoscopic nephrectomy, adrenalectomy and nephroureterectomy. Eur Urol. 1993. 23(4):425-30. [Medline].
Winfield HN, Donovan JF, Godet AS, Clayman RV. Laparoscopic partial nephrectomy: initial case report for benign disease. J Endourol. 1993 Dec. 7(6):521-6. [Medline].
Nakada SY, Moon TD, Gist M, Mahvi D. Use of the pneumo sleeve as an adjunct in laparoscopic nephrectomy. Urology. 1997 Apr. 49(4):612-3. [Medline].
Tait C, Tandon S, Baker L, Goodman C, Townell N, Nabi G. Long-term oncologic outcomes of laparoscopic radical nephrectomy for kidney cancer resection: Dundee cohort and metaanalysis of observational studies. Surg Endosc. 2011 Oct. 25(10):3154-61. [Medline].
Rassweiler JJ, Abbou C, Janetschek G, Jeschke K. Laparoscopic partial nephrectomy. The European experience. Urol Clin North Am. 2000 Nov. 27(4):721-36. [Medline].
Heuer R, Gill IS, Guazzoni G, Kirkali Z, Marberger M, Richie JP. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol. 2010 Feb. 57(2):223-32. [Medline].
Mottrie A, De Naeyer G, Schatteman P, Carpentier P, Sangalli M, Ficarra V. Impact of the learning curve on perioperative outcomes in patients who underwent robotic partial nephrectomy for parenchymal renal tumours. Eur Urol. 2010 Jul. 58(1):127-32. [Medline].
Rogers C, Sukumar S, Gill IS. Robotic partial nephrectomy: the real benefit. Curr Opin Urol. 2011 Jan. 21(1):60-4. [Medline].
Hyams E, Pierorazio P, Mullins JK, Ward M, Allaf M. A Comparative Cost Analysis of Robot-Assisted Versus Traditional Laparoscopic Partial Nephrectomy. J Endourol. 2012 Feb 24. [Medline].
Kates M, Ball MW, Patel HD, Gorin MA, Pierorazio PM, Allaf ME. The financial impact of robotic technology for partial and radical nephrectomy. J Endourol. 2015 Mar. 29 (3):317-22. [Medline].
Yates DR, Vaessen C, Roupret M. From Leonardo to da Vinci: the history of robot-assisted surgery in urology. BJU Int. 2011 Dec. 108(11):1708-13; discussion 1714. [Medline].
Abbou CC, Hoznek A, Salomon L, Lobontiu A, Saint F, Cicco A, et al. [Remote laparoscopic radical prostatectomy carried out with a robot. Report of a case]. Prog Urol. 2000 Sep. 10(4):520-3. [Medline].
Orvieto MA, Patel VR. Evolution of robot-assisted radical prostatectomy. Scand J Surg. 2009. 98(2):76-88. [Medline].
Rogers CG, Patard JJ. Open to debate. The motion: Robotic partial nephrectomy is better than open partial nephrectomy. Eur Urol. 2009 Sep. 56(3):568-70. [Medline].
Braga LH, Pace K, DeMaria J, Lorenzo AJ. Systematic review and meta-analysis of robotic-assisted versus conventional laparoscopic pyeloplasty for patients with ureteropelvic junction obstruction: effect on operative time, length of hospital stay, postoperative complications, and success rate. Eur Urol. 2009 Nov. 56(5):848-57. [Medline].
Touijer K, Jacqmin D, Kavoussi LR, Montorsi F, Patard JJ, Rogers CG, et al. The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol. 2010 Feb. 57(2):214-22. [Medline].
Brandao LF, Zargar H, Autorino R, Akca O, Laydner H, Samarasekera D, et al. Robot-assisted partial nephrectomy for ≥ 7 cm renal masses: a comparative outcome analysis. Urology. 2014 Sep. 84 (3):602-8. [Medline].
Okhunov Z, Rais-Bahrami S, George AK, Waingankar N, Duty B, Montag S. The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol. 2011 Dec. 25(12):1921-4. [Medline].
Canter D, Kutikov A, Manley B, Egleston B, Simhan J, Smaldone M. Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology. 2011 Nov. 78(5):1089-94. [Medline].
Hu JC, Treat E, Filson CP, McLaren I, Xiong S, Stepanian S, et al. Technique and outcomes of robot-assisted retroperitoneoscopic partial nephrectomy: a multicenter study. Eur Urol. 2014 Sep. 66 (3):542-9. [Medline].
Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010 Sep. 58(3):340-5. [Medline].
Aron M, Koenig P, Kaouk JH, Nguyen MM, Desai MM, Gill IS. Robotic and laparoscopic partial nephrectomy: a matched-pair comparison from a high-volume centre. BJU Int. 2008 Jul. 102(1):86-92. [Medline].
Kaul S, Laungani R, Sarle R, Stricker H, Peabody J, Littleton R, et al. da Vinci-assisted robotic partial nephrectomy: technique and results at a mean of 15 months of follow-up. Eur Urol. 2007 Jan. 51(1):186-91; discussion 191-2. [Medline].
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000 Feb. 163(2):442-5. [Medline].
Patel MN, Bhandari M, Menon M, Rogers CG. Robotic-assisted partial nephrectomy. BJU Int. 2009 May. 103(9):1296-311. [Medline].
Allaf M, Patriciu A, Mazilu D, Kavoussi L, Stoianovici D. Overview and fundamentals of urologic robot-integrated systems. Urol Clin North Am. 2004 Nov. 31(4):671-82, vii. [Medline].
Patel MN, Krane LS, Bhandari A, Laungani RG, Shrivastava A, Siddiqui SA, et al. Robotic partial nephrectomy for renal tumors larger than 4 cm. Eur Urol. 2010 Feb. 57(2):310-6. [Medline].
Dulabon LM, Kaouk JH, Haber GP, Berkman DS, Rogers CG, Petros F, et al. Multi-institutional analysis of robotic partial nephrectomy for hilar versus nonhilar lesions in 446 consecutive cases. Eur Urol. 2011 Mar. 59(3):325-30. [Medline].
Naeem N, Petros F, Sukumar S, Patel M, Bhandari A, Kaul S, et al. Robot-assisted partial nephrectomy in obese patients. J Endourol. 2011 Jan. 25(1):101-5. [Medline].
Petros FG, Angell JE, Abaza R. Outcomes of Robotic Nephrectomy Including Highest-complexity Cases: Largest Series to Date and Literature Review. Urology. 2015 Jun. 85 (6):1352-8. [Medline].
Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology. 2004 Nov. 64(5):914-8. [Medline].
Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, et al. Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol. 2008 Dec. 180(6):2353-6; discussion 2356. [Medline]. [Full Text].
Benway BM, Wang AJ, Cabello JM, Bhayani SB. Robotic partial nephrectomy with sliding-clip renorrhaphy: technique and outcomes. Eur Urol. 2009 Mar. 55(3):592-9. [Medline].
Wang AJ, Bhayani SB. Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. Urology. 2009 Feb. 73(2):306-10. [Medline].
White WM, Goel RK, Haber GP, Kaouk JH. Robotic partial nephrectomy without renal hilar occlusion. BJU Int. 2010 Jun. 105(11):1580-4. [Medline].
Gong Y, Du C, Josephson DY, Wilson TG, Nelson R. Four-arm robotic partial nephrectomy for complex renal cell carcinoma. World J Urol. 2010 Feb. 28(1):111-5. [Medline].
Petros FG, Patel MN, Kheterpal E, Siddiqui S, Ross J, Bhandari A, et al. Robotic partial nephrectomy in the setting of prior abdominal surgery. BJU Int. 2011 Aug. 108(3):413-9. [Medline].
Laydner H, Autorino R, Spana G, Altunrende F, Yang B, Khanna R, et al. Robot-assisted partial nephrectomy for sporadic ipsilateral multifocal renal tumours. BJU Int. 2012 Jan. 109(2):274-80. [Medline].
Abreu AL, Gill IS, Desai MM. Zero-ischaemia robotic partial nephrectomy (RPN) for hilar tumours. BJU Int. 2011 Sep. 108(6 Pt 2):948-54. [Medline].
Spana G, Haber GP, Dulabon LM, Petros F, Rogers CG, Bhayani SB, et al. Complications after robotic partial nephrectomy at centers of excellence: multi-institutional analysis of 450 cases. J Urol. 2011 Aug. 186(2):417-21. [Medline].
Kaouk JH, Hillyer SP, Autorino R, Haber GP, Gao T, Altunrende F, et al. 252 robotic partial nephrectomies: evolving renorrhaphy technique and surgical outcomes at a single institution. Urology. 2011 Dec. 78(6):1338-44. [Medline].
Guillotreau J, Haber GP, Autorino R, Miocinovic R, Hillyer S, Hernandez A, et al. Robotic Partial Nephrectomy Versus Laparoscopic Cryoablation for the Small Renal Mass. Eur Urol. 2012 Jan 14. [Medline].
Weizer AZ, Palella GV, Montgomery JS, Miller DC, Hafez KS. Robot-assisted retroperitoneal partial nephrectomy: technique and perioperative results. J Endourol. 2011 Apr. 25(4):553-7. [Medline].
Phillips CK, Taneja SS, Stifelman MD. Robot-assisted laparoscopic partial nephrectomy: the NYU technique. J Endourol. 2005 May. 19(4):441-5; discussion 445. [Medline].
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009 Jun. 7(6):618-30. [Medline].
Rashid HH, Cambio AJ, Wu G. A Novel Upside Arm Adducted Arm Positioning for Robotic- assisted Transperitoneal Upper Tract Surgery to Eliminate Robotic Arm Interference. Journal of Urology AUA Supplement. 2010/04. 183 No. 4:e350.
Ahmad G, Duffy JM, Phillips K, Watson A. Laparoscopic entry techniques. Cochrane Database Syst Rev. 2008 Apr 16. CD006583. [Medline].
Gong EM, Zorn KC, Orvieto MA, Lucioni A, Msezane LP, Shalhav AL. Artery-only occlusion may provide superior renal preservation during laparoscopic partial nephrectomy. Urology. 2008 Oct. 72(4):843-6. [Medline].
Shikanov S, Wille M, Large M, Lifshitz DA, Zorn KC, Shalhav AL, et al. Knotless closure of the collecting system and renal parenchyma with a novel barbed suture during laparoscopic porcine partial nephrectomy. J Endourol. 2009 Jul. 23(7):1157-60. [Medline].
Porpiglia F, Fiori C, Bertolo R, Angusti T, Piccoli GB, Podio V, et al. The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients with normal contralateral kidney. World J Urol. 2011 Jul 19. [Medline].
Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M. Trocar site hernia. Arch Surg. 2004 Nov. 139(11):1248-56. [Medline].
Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009 Dec 1. 27(34):5794-9. [Medline].
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr. 61(2):69-90. [Medline].
Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011 Jul. 60(1):39-44. [Medline].
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 1. 113(1):78-83. [Medline].
|Series||Number of Patients||Total Number of Masses||Follow-up Time, Months||Operative Time, Minutes||Mean Length of Stay||Estimated Blood Loss, mL||Tumor Size, cm||Cancer (%)|
|Gettman et al (2004)||13||13||7||215||4.3||170||3.5||10 (76.9)|
|Kaul et al (2007)||10||10||15||155||1.5||92||2.3||8 (80)|
|Rogers et al (2008)||8||14||3||192||2.6||230||3.6||8 (60)|
|Rogers et al (2008)||11||11||NR||202||2.6||220||3.8||11 (100)|
|Benway et al (2009)||50||50||NR||145.3||2.5||140||2.7||28 (56)|
|Wang et al (2009)||40||40||NR||140||2.5||136||2.5||25 (62)|
|White et al (2009)||20||20||NR||197||4.05||220||2.72||NR|
|Patel et al (2010)||71||71||6.8||245.9||2||100||2.71||51 (72)|
|Gong et al (2010)||29||29||15||197||2.5||220||3||21 (72)|
|Petros et al (2011)||95||95||NR||248.3||2||122||2.39||68 (72)|
|Laydner et al (2011)||8||19||14||199||4.75||250||2.2||16 (84)|
|Abreu et al (2011)||7||7||NR||237||4||229||3.4||6 (86)|
|Dulabon et al (2011)||446||446||NR||188.1||2.88||213||3.02||333 (75)|
|Spana et al (2011)||450||NR||NR||188||NR||206||2.91||NR|
|Kaouk et al (2011)||187||NR||6||181.4||3.64||248||3.15||171 (69)|
|Guillotreau et al (2012)||210||212||4.8||180||3||200||2.4||156 (74)|
|NR = not recorded|
|Series||Arterial clamping (%)||Clamp Time, Minutes||Positive Margin (%)|
|Gettman et al (2004)||5 (38.5)||22||1 (7.7)|
|Kaul et al (2007)||7 (70)||21||0 (0)|
|Rogers et al (2008)||NR||31||0 (0)|
|Rogers et al (2008)||11 (100)||28.9||0 (0)|
|Benway et al (2009)||NR||17.8||1 (2)|
|Wang et al (2009)||40 (100)||19||1 (2)|
|White et al (2009)||20 (100)||23.8||NR|
|Patel et al (2010)||57 (80)||21.1||3 (4)|
|Gong et al (2010)||29 (100)||25||0 (0)|
|Petros et al (2011)||NR||17.7||NR|
|Laydner et al (2011)||13 (68)||21||0 (0)|
|Abreu et al (2011)||0 (0)||NA||0 (0)|
|Dulabon et al (2011)||NR||20.22||7 (1)|
|Spana et al (2011)||NR||20.2||NR|
|Kaouk et al (2011)||NR||18||NR|
|Guillotreau et al (2012)||NR||17||3 (1)|
|NR = not recorded; NA = not applicable|
|Series||Intraoperative Complications (%)||Clavien-Grade 1 and 2 (%)||Clavien-Grade 3 and 4 (%)||Transfusion (%)||Recurrences (%)|
|Gettman et al (2004)||0 (0)||1 (7.7)||0 (0)||0 (0)||0 (0)|
|Kaul et al (2007)||0 (0)||2 (20)||1 (10)||1 (10)||0 (0)|
|Rogers et al (2008)||0 (0)||0 (0)||0 (0)||0 (0)||0 (0)|
|Rogers et al (2008)||0 (0)||0 (0)||2 (18)||0 (0)||NR|
|Benway et al (2009)||3 (6)||4 (8)||1 (2)||2 (4)||0 (0)*|
|Wang et al (2009)||2 (5)||7 (18)||1 (2)||2 (5)||NR|
|White et al (2009)||0 (0)||4 (20)||1 (5)||3 (15)||NR|
|Patel et al (2010)||1 (1)||4 (6)||3 (4)||2 (3)||0 (0)*|
|Gong et al (2010)||0 (0)||0 (0)||0 (0)||0 (0)||0 (0)|
|Petros et al (2011)||2 (2)||4 (4)||3 (3)||2 (2)||NR|
|Laydner et al (2011)||0 (0)||1 (5)||0 (0)||0 (0)||NR|
|Abreu et al (2011)||0 (0)||2 (29)||0 (0)||1 (14)||NR|
|Dulabon et al (2011)||10 (2)||16 (4)||1 (0.2)||18 (4)||1 (0.2)|
|Spana et al (2011)||1 (0.2)||54 (12)||17 (4)||18 (4)||NR|
|Kaouk et al (2011)||3 (1)||42 (17)||6 (2)||17 (9)||NR|
|Guillotreau et al (2012)||7 (3)||36 (17)||6 (3)||NR||0 (0)|
|NR = not recorded
*None at 12 months follow-up
|Series||Preoperative Serum Creatinine level, mg/dL||Preoperative eGFR, mL/min/1.73 m2||Postoperative Serum Creatinine level, mg/dL||Postoperative eGFR, mL/min/1.73 m2||Increased
Postoperative Serum Creatinine level, mg/dL
Postoperative eGFR, mL/min/1.73 m2
|Rogers et al (2008)||0.9||84.9||0.93||79.3||0.03||5.6|
|Rogers et al (2008)||NR||82.7||NR||74.7||NR||8|
|Benway et al (2009)||1.12||NR||1.12||NR||0||NR|
|White et al (2009)||0.86||NR||1.02||NR||0.16||NR|
|Patel et al (2010)||NR||76.2||NR||73.9||NR||2.3|
|Gong et al (2010)||NR||NR||NR||NR||NR||4.5|
|Laydner et al (2011)||1.08||74||1.2||70.25||0.12||3.75|
|Abreu et al (2011)||1.1||65.6||1.3||67||0.2||-1.4|
|Kaouk et al (2011)||0.89||86.3||86.35||82.08||0.05||4.22|
|Guillotreau et al (2012)||0.94||86.3||NR||76||NR||10.3|
|NR = not recorded|